chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a medical assistant referring to a 6 months old female patient. No relevant medical history or concurrent conditions were reported. On 03-JUN-2015, the patient was inadvertently vaccinated with improperly stored ROTATEQ (lot # K014826, expiration date 28-MAY-2016; dose was not reported) orally. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Patient has extreme stiff neck/lymph node swelling. Lasted 8 days duration. Could barely turn head. States she has 4 other associates with same reaction.
Missed her second dose because she was sick; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed her second dose because she was sick) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed her second dose because she was sick). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missed her second dose because she was sick) had resolved.            Concomitant medications were not provided. Treatment information was not reported.   Treatment information was not provided.   This case was linked to MOD-2021-048873 (Patient Link).
Rash at injection sight with swollen lympnodes under left arm pit and rash spreading around arm
Tested positive for covid; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested positive for covid) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for covid). At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for covid) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test positive: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient had taken Regeneron through IV  Patient had received monoclonal antibody shot  No concomitant information was provided.
Patient said she experienced swelling, stiffness and bruising in her arm. She couldn't move her arm, and still has difficulty moving her arm. The swelling went down. The arm pain and bruising went down over time, but still experiencing arm pain and still some bruising. She contacted her primary doctor, which she spoke to the nurse. The nurse advised her to monitor and see if the symptoms improve and contact the office again if it doesn't. Patient will contact the MD office if her symptoms don't get better by the end of this week.
Clinic contacted patient date of death: 05/09/2021. No other information on symptoms, signs experienced prior to time of death.
I had severe pain after the shot around my left eye and temple area and diarrhea, more recently I have a pain around the back of my left leg, right above the knee area. And the front of my left leg looks and feels bruised as it I was struck by something
Patient did not remain seated for 15 minutes post-vaccination as instructed. He fainted and hit his head. He regained consciousness quickly, but remained diaphoretic with bradycardia. He was provided water and an icepack, and he was instructed to lay flat with legs elevated until he recovered.
Pt is a 67 y.o. female with a PMH of renal transplant, recurrent UTI, depression, GERD, hyperparathyroidism, hypothyroidism, DM II, and restless leg syndrome. Per chart review, patient presented to OSH with o2 saturation of 88% on RA. Upon evaluation at the OSH, the patient was maintaining o2 saturation of 91% on RA even with ambulation. Patient was diagnosed with COVID 19 on 9/24/21 and the patient stated that since yesterday, she has been having dyspnea. Patient denied history of COPD, home oxygen use, or asthma. Patient stated she has been having a productive grey sputum with coughs for the past 4 days. Patient also endorsed chest tightness when coughing but denied any chest pain. Patient endorsed one low grade fever of 99.9 as well as chills. Patient endorsed diarrhea four days ago and last episode of diarrhea was yesterday morning. Patient stated that there was no melena or bright red blood in her stool. Patient endorsed flank pain without bilateral CVA tenderness and endorsed a frontal headache and stated she has taken Tylenol at home which has helped with her headache. Patient is immunocompromised with history of kidney transplant and high risk for serious COVID 19 complications and was sent to UK after discussion with the renal transplant team. Patient was also found to have an AKI. Upon assessment, patient was alert and oriented in no acute distress. Patient was on 5LNC with o2 saturation of 95% with RR of 18.   Constitutional: Positive for chills and fever. Negative for unexpected weight change.       Low grade fever   HENT: Negative for congestion, hearing loss, sore throat, tinnitus and trouble swallowing.        Loss of taste or smell   Eyes: Negative for pain, redness and visual disturbance.  Respiratory: Positive for cough, chest tightness and shortness of breath. Negative for wheezing.    Hospital course:   She was hospitalized and treated with remdesivir and dexamethasone per protocol. She required HFNC, but was eventually weaned back to NC on 10/7 and remained stable off that. Patient requested to be discharged home on 10/8 and we agreed that if oxygenation remained stable that discharge was acceptable. On day of discharge Oxygen was weaned to 3L NC during exam with patient which she tolerated well. She agreed to return to the ED should she become more SOA, which is only 10 minutes form her house.  Disposition: Home with Home Health Condition: Stable (s/sx potential problems absent or manageable)
AT APPROXIMATLY 11:20AM  (ABOUT 5 MINUTES AFTER INJECTION) PATIENT STARTED TO FEEL NAUSEOUS. AN EMPTY GARBAGE WAS BROUGHT NEAR THE PATIENT, ALONG WITH A COLD WET PAPERTOWEL TOO APPY TOTHEIR NECK AND FOREHEAD. CHAIRS WERE ARRANGED NEXT TO EACHOTHER SO THEY COULD LAY DOWN IF THEY NEED TO. EMERGENCY WAS CALLED IMMEDIATELY AND ARRIVED AT ABOUT 11: 30AM. THEY THEN TALKED TO PATIENT AND PARENTS. AT ABOUT 11:40AM THE PARAMEDICS LEFT WITHOUT THE PATIENT AND THE PATIENT WENT HOME SAFELY WITH HIS PARENTS.
I started cramping and when the ultrasound was done on September 10 2021, I measured 5 weeks 2 days and I should have been 6 weeks 2 days. My baby stopped growing the day I received the second vaccination, which then resulted in a miscarriage.
I was fine the first couple of days but after a while i had arm soreness and redness on the arm and upper arm was very painful
Moderate itching at site and spreading  to  upper arm. Redness with  itchy splotches.
dime sized bleached out mark were the tattoo was red in color; I have a bleached out spot on my tattoo where I got my second vaccine/ I  do not know of it bled so much it left that spot bare of ink or it was from the shot itself; could not maintain a normal temperature it fluctuated; flu-like symptoms; whole body aches; joints hurt; headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (I have a bleached out spot on my tattoo where I got my second vaccine/ I  do not know of it bled so much it left that spot bare of ink or it was from the shot itself), BODY TEMPERATURE FLUCTUATION (could not maintain a normal temperature it fluctuated), INFLUENZA LIKE ILLNESS (flu-like symptoms), SKIN DISCOLOURATION (dime sized bleached out mark were the tattoo was red in color) and PAIN (whole body aches) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 078C21A and 050C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 15-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Jul-2021, the patient experienced BODY TEMPERATURE FLUCTUATION (could not maintain a normal temperature it fluctuated), INFLUENZA LIKE ILLNESS (flu-like symptoms), PAIN (whole body aches), ARTHRALGIA (joints hurt) and HEADACHE (headache). On 16-Jul-2021, the patient experienced VACCINATION SITE DISCOLOURATION (I have a bleached out spot on my tattoo where I got my second vaccine/ I  do not know of it bled so much it left that spot bare of ink or it was from the shot itself). On an unknown date, the patient experienced SKIN DISCOLOURATION (dime sized bleached out mark were the tattoo was red in color). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. On 17-Jul-2021, BODY TEMPERATURE FLUCTUATION (could not maintain a normal temperature it fluctuated), INFLUENZA LIKE ILLNESS (flu-like symptoms), PAIN (whole body aches), ARTHRALGIA (joints hurt) and HEADACHE (headache) had resolved. At the time of the report, VACCINATION SITE DISCOLOURATION (I have a bleached out spot on my tattoo where I got my second vaccine/ I  do not know of it bled so much it left that spot bare of ink or it was from the shot itself) and SKIN DISCOLOURATION (dime sized bleached out mark were the tattoo was red in color) outcome was unknown.            No concomitant medications were provided.   This case was linked to MOD-2021-285512 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-Aug-2021: Significant follow-up information contains: reporter details, patient age,gender and added events-pain, arthralgia, influenza like illness, headache, body temp fluctuations, erythema, vaccination site discoloration
This case was reported by a pharmacist via call center representative and described the occurrence of injection site swelling in a female patient who received SHINGRIX (batch number 9NJ59, expiry date 8th February 2021) for prophylaxis. On 13th July 2018, the patient received the 1st dose of SHINGRIX. In July 2018, less than a week after receiving SHINGRIX, the patient experienced injection site swelling, injection site erythema, fainting, shivering, fatigue, radiating pain, fever, injection site warmth and injection site induration. On an unknown date, the outcome of the injection site swelling, injection site erythema, fatigue and radiating pain were not recovered/not resolved and the outcome of the fainting, shivering and fever were recovered/resolved and the outcome of the injection site warmth and injection site induration were unknown. It was unknown if the reporter considered the injection site swelling, injection site erythema, fainting, shivering, fatigue, radiating pain, fever, injection site warmth and injection site induration to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The pharmacist said that this patient came back into the pharmacy to speak to the pharmacist about the side effects she experienced. The patient told the pharmacist that at the injection site, her skin was warm, red, swollen and hard. After the vaccination, the patient went back to work but had to leave because of more side effects. The patient said that she started shivering, had fever and felt like she might faint. There was pain that radiated from her arm around to the back of her neck. This information was all that the reporter had now. The reporter said she might reach out to the customer to get more information from her and possibly speak to medical information about the vaccine.
Patient experienced swelling, redness, and warmth in R arm where vaccination was administered. It started with pink to red splotches and increased over the course of 24 hours. Patient went to local urgent care and received antibiotic to treat cellulitis
The vaccine expired past the 30-day recommendation. At this time there have been no s/s of any adverse events
This case was reported by a pharmacist via call center representative and described the occurrence of stiff neck in a male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX. On an unknown date, less than a year after receiving This case was reported by a pharmacist via call center representative and described the occurrence of stiff neck in a male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced stiff neck and neck pain. On an unknown date, the outcome of the stiff neck and neck pain were unknown. It was unknown if the reporter considered the stiff neck and neck pain to be related to SHINGRIX. Additional details were received as follows: The age at vaccination was not reported. The reporter did not have batch number at the time of reporting. The patient experienced stiff neck after a dose of SHINGRIX. The patient reported that it hurts if he turns his head to the right or left. The pharmacist was unsure if the symptoms started after each dose and if it resolved after the first dose and then came back again after the second dose. The patient did see his physician.
Local symptoms- very mild pain-discomfort. General symptoms- chills, fever, headaches, muscle pains, fatigue, nausea.  Narrative:
Not sleeping well; Throwing up; Hot and cold flashes; Can't eat; Hot and cold flashes; This is a spontaneous report from a contactable consumer reported for patient (father). A male patient of an unspecified age received BNT162B2 via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient has got the shot whatever it is, the vaccine. And he has got it on Sunday. And since Sunday night he has been not sleeping well, throwing up, hot and cold flashes, can't eat. Events outcome was unknown.  Information about lot/batch number has been requested.
Next day, approximately 19 hours after receiving injection, felt like I was hit by a truck. Energy down to almost nothing, sore all over, especially at the site of the injection. Running a 101 degree fever reduced after 3-4 hours by administering 800 mg of ibuprofen. Was off work for two days and did not feel like normal until 3 days afterwards (Saturday evening).
Labored breathing, broke out in pus filled bumps all over my body (not just in localized area like vaccine should caused).
feeling dizzy; tingling sensation and twitching sensation that comes and goes; tingling sensation and twitching sensation that comes and goes; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 55-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19  VACCINE; Formulation: Solution for injection, lot number and Expiration date were not provided) on 04Mar2021 (also reported as 16 days ago) via unspecified route of administration at SINGLE DOSE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date in Mar2021 (also reported as last night) the patient experienced feeling dizzy and a tingling sensation and twitching sensation that comes and goes. There was side effect mentioned. There was no PQC present. The outcome of the events was unknown.   Information on Lot/Batch number has been requested.
Pregnancy symptoms lost. Two weeks later ultrasound confirmed development of embryo stopped at 5 weeks.
Following administration of vaccines (approximately 10-15 min) patient fainted, fell to floor and sustained a right clavicular fracture.
18JUN 2 days post vax there is a local erythema w/bluish discoloration @ site of inject; mom advised to see MD if discoloration @ inject site becomes pustular;
That feels real bad; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53 year-old patient received bnt162b2 (BNT162B2), administered in arm left, administration date 13Aug2021 (Lot number: FC3180) at the age of 53 years as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "Diabetes mellitus" (unspecified if ongoing), notes: Diabetes; "Sarcoid" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: FEELING ABNORMAL (non-serious) with onset Aug2021, outcome "unknown", described as "That feels real bad". Therapeutic measures were not taken as a result of feeling abnormal.  Follow-up attempts are completed. No further information is expected.
Period began a full 7 days early and premenstrual symptoms (cramps, headaches, backache) were extremely much more intense than normal.  The menstrual cramps were debilitatingly strong which is not normal for me.
Left arm from top of shoulder to his elbow inflamed - hot to touch 7x5 total area, arm is dark red in color.  ER visit 07/14/2000, Benadryl - 1 tsp every 6 hours, 1 tsp motrin or tylenol.
Patient received the HPV as well as the flu nasal spray on Aug 25th.  I first declined getting her the vaccination but her doctor ensured me that it was safe.  I had declined the same vaccination a year earlier at the downtown public health center. Patient was getting ready for school and was standing by her closet, and all of a sudden she fell, she lost total control of her legs.  She went to school and could not engage in any of the activities because of the numbness in her legs and the swelling of her foot.  She also, started to get a really bad headache.  Days later she woke up out of her sleep complaining of a severe headache, which usually she gets if she has a seizure but she hadn't had a seizure this night.  She continued to say she had not feeling in her foot and tingling feeling in her leg.  After I examined her foot I noticed it was swollen.  The next morning I called her doctors office and made her doctors appointment for Oct 23rd.  During the month of October she had irregular periods.  My daughter never made it to Oct 23rd, which as also her birthday.  She passed on Oct. 17th, I found her cold unresponsive in her room at 7am, which I went in to wake her up to take her morning pills.
Client c/o swelling on site vaccine given, LD and some pressure when swallowing.  Client reports having a headache on first COVID-19 dose.  Site assessed and no swelling noted on LD, nor pain reported.  No swelling observed near throat area.  Upon client departure at 10:30 am, client was able to move arm and speak/swallow with no difficulties.  Client advised to contact PCP if any other issues occur at home.  Client verbalized understanding.  Client assessed by EMT and nursing onsite.  All vitals within normal limits.
Received on MMR II and Tdap on 10/1/08. Pt is a nurse and saw a PA at the hospital where she works. The pt. c/o aching all over, headache, soreness in the arms and joints. The MMR II shot was raised with redness more than a 50c piece, hurt to touch, hot to touch and red. Is having some itching at the site now.
Red, round circle, warm to touch, ~4in around injection site, with flushed cheeks. No fever. Taking BENADRYL and PEPCID for the reaction.
employee tested positive for COVID on 3/8/2021 greter tahn 14 days post vaccination , however was postitive 12/8/2020 90days ago Narrative:  previous positive 12/8/2020 vaccinated 2nd dose 2/12 retests 3/8 positive part of surveillance working on long term care ward
Breakthrough case admission after 3 vaccines  Moderna 2/15/21 Lot# 038K20A;  Moderna 3/15/21 Lot# 030A21A;  Moderna 10/13/21 NO LOT #
Migraine type headache; This is a spontaneous report from a contactable consumer(patient). A 50-years-old non pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot Number: EL9269), via an Intramuscular route of administration on 13Feb2021 at 10:00(at the age of 50-years-old) administered in Arm Right as a single dose for COVID-19 immunisation. The patient had received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot Number: EL9261), via an Intramuscular route of administration on 26Jan2021 at 20:00(at the age of 50-years-old) administered in Upper right arm as a single dose for COVID-19 immunisation. Medical history included epstein barr virus positive mucocutaneous ulcer from 2010 and ongoing, Penicillin allergies from an unknown date and unknown if ongoing , Low thryoid function from 2015 and ongoing , thyroid from an unknown date and unknown if ongoing, Chronic pain from an unknown date and unknown if ongoing. Concomitant medication(s) included tramadol taken for pain from an unspecified start date and ongoing; cyanocobalamin (B12) taken for epstein barr virus positive mucocutaneous ulcer from an unspecified start date and ongoing; levothyroxine sodium (LEVOTHYROXINE) taken for thyroid disorder from an unspecified start date and ongoing; liothyronine sodium (LIOTHYRONINE) taken for thyroid disorder from an unspecified start date and ongoing. On 13Feb2021 at 22:00, the patient experienced Migraine type headache. The patient had received advil as a treatment medication. The outcome of the event was recovered.  No follow-up attempts are possible. No further information is expected.
redness, pain and swelling began 7 day post injection. I also have unexplained bruising on my leg and thigh
Rec'd PREVENAR 13 shot, left clinic and shortly afterwards, fainted on the expressway while driving motorcycle.
Information has been received from a doctor's licensed practical nurse concerning a 50 year old female patient who was post menopausal and had never had children and with a history of breast cancer who on 21-MAY-2010 was vaccinated with the first 0.5mL dose of GARDASIL. Concomitant therapy included TAMIFEN. On 28-MAY-2010 the patient called the office stating she had vaginal bleeding. The patient sought unspecified medical attention. No laboratory diagnostic studies were performed. The doctor would discuss ultrasound testing with the patient. At the time of the report, the patient's outcome was unspecified. Additional information has been requested.
Red Circle around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Red Circle around the injection site) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red Circle around the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (Red Circle around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant medications were not provided by reporter.
Client presented to clinic 2 days after receiving Zostavax injection with an approx 40x48mm red raised indurated area at the injection site, it felt mildly warm to touch, and cl said it was itchy, and a little sore.  Client states it started about 18 hrs after vaccine administration.  Client otherwise felt "fine."  Advised cool compress to site for comfort, to see PCP if worsens.  Client returned to the clinic 6/27, 6 days after injection to show this RN that symptoms had resolved other than residual bruising.  Spoke with client 7/16/09 and she states issue completely resolved.